JAK-STAT Signaling

Handbook of Cell Signaling, Second Edition

Volumn 3, Issue , 2009, Pages 2041-2048

  Song, Li ^a   Schindler, Christian ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863097943     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374145-5.00249-7     Document Type: Chapter

References (74)

1. T Decker, M Muller and S Stockinger (2005) The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 5(9), 675-687.
2. PJ Murray (2007) The JAK–STAT signaling pathway: input and output integration. J Immunol 178(5), 2623-2629.
3. S Pestka, CD Krause, D Sarkar, MR Walter, Y Shi, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22 929-979.
4. DE Levy Jr. and JE Darnell (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3(9), 651-662.
5. T Kisseleva, S Bhattacharya, J Braunstein and CW Schindler (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285(1–2), 1-24.
6. I Remy, IA Wilson and SW Michnick (1999) Erythropoietin receptor activation by a ligand-induced conformation change. Science 283(5404), 990-993.
7. GR Stark, IM Kerr, BR Williams, RH Silverman and RD Schreiber (1998) How cells respond to interferons. Annu Rev Biochem 67 227-264.
8. X Chen, U Vinkemeier, Y Zhao, D Jeruzalmi, JE Darnell Jr., et al. (1998) Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93(5), 827-839.
9. C Mertens, M Zhong, R Krishnaraj, W Zou, X Chen, et al. (2006) Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. Genes Dev 20(24), 3372-3381.
10. D Neculai, AM Neculai, S Verrier, K Straub, K Klumpp, et al. (2005) Structure of the unphosphorylated STAT5a dimer. J Biol Chem 280(49), 40,782-40,787.
11. S Becker, B Groner and CW Muller (1998) Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394(6689), 145-151.
12. X Mao, Z Ren, GN Parker, H Sondermann, MA Pastorello, et al. (2005) Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell 17(6), 761-771.
13. KM McBride and NC Reich (2003) The ins and outs of STAT1 nuclear transport. Sci STKE 2003(195), RE13.
14. T Decker, P Kovarik and A Meinke (1997) GAS elements: A few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17(3), 121-134.
15. W Zhao, C Lee, R Piganis, C Plumlee, N de Weerd, et al. (2008) A Conserved IFN-α Receptor Tyrosine Motif Directs the Biological Response to Type I IFNs. J Immunol 180(8), 5483-5489.
16. TC Wagner, S Velichko, D Vogel, MR Rani, S Leung, et al. (2002) Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells. J Biol Chem 277(2), 1493-1499.
17. W Zhao, EN Cha, C Lee, CY Park and C Schindler (2007) Stat2-Dependent Regulation of MHC Class II Expression. J Immunol 179(1), 463-471.
18. K Shuai (2000) Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19(21), 2638-2644.
19. T Tanaka, MA Soriano and MJ Grusby (2005) SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity 22(6), 729-736.
20. U Klingmueller, U Lorenz, LC Cantley, BG Neel and HF Lodish (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 80(5), 729-738.
21. T Mustelin, T Vang and N Bottini (2005) Protein tyrosine phosphatases and the immune response. Nat Rev Immunol 5(1), 43-57.
22. M Nakahira, T Tanaka, BE Robson, JP Mizgerd and MJ Grusby (2007) Regulation of Signal Transducer and Activator of Transcription Signaling by the Tyrosine Phosphatase PTP-BL. Immunity 26(2), 163-176.
23. U Vinkemeier (2004) Getting the message across, STAT! Design principles of a molecular signaling circuit. J Cell Biol 167(2), 197-201.
24. S Bhattacharya and C Schindler (2003) Regulation of Stat3 nuclear export. J Clin Invest 111(4), 553-559.
25. WS Alexander and DJ Hilton (2004) The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 22 503-529.
26. JE Fenner, R Starr, AL Cornish, JG Zhang, D Metcalf, et al. (2006) Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol 7(1), 33-39.
27. CV Rothlin, S Ghosh, EI Zuniga, MB Oldstone and G Lemke (2007) TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response. Cell 131(6), 1124-1136.
28. PC Heinrich, I Behrmann, S Haan, HM Hermanns, G Muller-Newen, et al. (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374(Pt 1), 1-20.
29. CJ Greenhalgh, E Rico-Bautista, M Lorentzon, AL Thaus, PO Morgan, et al. (2005) SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 115(2), 397-406.
30. I Firmbach-Kraft, M Byers, T Shows, R Dalla-Favera and JJ Krolewski (1990) tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5(9), 1329-1336.
31. AF Wilks (1989) Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Nat Acad Sci, USA 86 1603-1607.
32. L Velazquez, M Fellous, GR Stark and S Pellegrini (1992) A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70(2), 313-322.
33. SJ Rodig, MA Meraz, JM White, PA Lampe, JK Riley, et al. (1998) Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93(3), 373-383.
34. H Neubauer, A Cumano, M Mueller, H Wu, U Huffstadt, et al. (1998) Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93(3), 397-409.
35. E Parganas, D Wang, D Stravopodis, DJ Topham, JC Marine, et al. (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93(3), 385-395.
36. A Tefferi (2008) JAK and MPL mutations in myeloid malignancies. Leuk Lymphoma 49(3), 388-397.
37. T Nosaka, JM vanDeursen, RA Tripp, WE Thierfelder, BA Witthuhn, et al. (1995) Defective lymphoid development in mice lacking Jak3. Science 270(5237), 800-802.
38. SY Park, K Saijo, T Takahashi, M Osawa, H Arase, et al. (1995) Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3(6), 771-782.
39. DC Thomis, CB Gurniak, E Tivol, AH Sharpe and LJ Berg (1995) Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270(5237), 794-797.
40. Y Seto, H Nakajima, A Suto, K Shimoda, Y Saito, et al. (2003) Enhanced Th2 cell-mediated allergic inflammation in Tyk2-deficient mice. J Immunol 170(2), 1077-1083.
41. M Karaghiosoff, H Neubauer, C Lassnig, P Kovarik, H Schindler, et al. (2000) Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13(4), 549-560.
42. K Shimoda, K Kato, K Aoki, T Matsuda, A Miyamoto, et al. (2000) Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity 13(4), 561-571.
43. Y Minegishi, M Saito, T Morio, K Watanabe, K Agematsu, et al. (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25(5), 745-755.
44. M Karaghiosoff, R Steinborn, P Kovarik, G Kriegshauser, M Baccarini, et al. (2003) Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 4(5), 471-477.
45. K Miyoshi, Y Cui, G Riedlinger, J Lehoczky, L Zon, et al. (2001) Structure of the mouse stat 3/5 locus: evolution from drosophila to zebrafish to mouse. Genomics 71(2), 150-155.
46. T Meyer, A Marg, P Lemke, B Wiesner and U Vinkemeier (2003) DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. Genes Dev 17(16), 1992-2005.
47. T Decker, M Müller and P Kovarik (2003) Regulation of Stats by posttranslational modification. PB Seghal, T Hirano, DE Levy (Eds) Signal transducers and activators of transcription (Stats): Activation and biology Dordrecht: Kluwer Academic
48. K Ramsauer, M Farlik, G Zupkovitz, C Seiser, A Kroger, et al. (2007) Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene. Proc Natl Acad Sci USA 104(8), 2849-2854.
49. D Wang, R Moriggl, D Stravopodis, N Carpino, JC Marine, et al. (2000) A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5. Embo J 19(3), 392-399.
50. D Maritano, ML Sugrue, S Tininini, S Dewilde, B Strobl, et al. (2004) The STAT3 isoforms alpha and beta have unique and specific functions. Nat Immunol 5(4), 401-409.
51. VN Ivanov, A Bhoumik, M Krasilnikov, R Raz, LB Owen-Schaub, et al. (2001) Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol Cell 7(3), 517-528.
52. X-Y Fu, C Schindler, T Improta, R Aebersold and JE Darnell (1992) The proteins of ISGF-3, the IFN-a induced transcription activator, define a new family of signal transducers. Proc Nat Acad Sci USA 89(16), 7840-7843.
53. C Schindler Jr., XY Fu, T Improta, R Aebersold and JE Darnell (1992) Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci USA 89(16), 7836-7839.
54. K Shuai, C Schindler, V Prezioso and JE Darnell (1992) Activation of transcription by IFN-g: Tyrosine phosphorylation of a 91-kDa DNA binding protein. Science 258(5089), 1808-1812.
55. JE Durbin, R Hackenmiller, MC Simon and DE Levy (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84(3), 443-450.
56. MA Meraz, JM White, KC Sheehan, EA Bach, SJ Rodig, et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84(3), 431-442.
57. C Park, S Li, E Cha and C Schindler (2000) Immune response in Stat2 knockout mice. Immunity 13(6), 795-804.
58. S Akira, Y Nishio, M Inoue, X-J Wang, S Wei, et al. (1994) Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77(1), 63-71.
59. D Jankovic and G Trinchieri (2007) IL-10 or not IL-10: that is the question. Nat Immunol 8(12), 1281-1283.
60. K Takeda, K Noguchi, W Shi, T Tanaka, M Matsumoto, et al. (1997) Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 94(8), 3801-3804.
61. K Takeda and S Akira (2000) STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev 11(3), 199-207.
62. G Inghirami, R Chiarle, WJ Simmons, R Piva, K Schlessinger, et al. (2005) New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle 4(9), 1131-1133.
63. WE Naugler and M Karin (2008) The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 14(3), 109-119.
64. N de la Iglesia, G Konopka, SV Puram, JA Chan, RM Bachoo, et al. (2008) Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 22(4), 449-462.
65. JF Bromberg, MH Wrzeszczynska, G Devgan, Y Zhao, RG Pestell, et al. (1999) Stat3 as an Oncogene. Cell 98(3), 295-303.
66. ZT Schafer and JS Brugge (2007) IL-6 involvement in epithelial cancers. J Clin Invest 117(12), 3660-3663.
67. DE Levy and CA Loomis (2007) STAT3 signaling and the hyper-IgE syndrome. N Engl J Med 357(16), 1655-1658.
68. CA Hunter (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5(7), 521-531.
69. Z Zhong, Z Wen and JE Darnell (1994) Stat3 and Stat4: Members of the family of signal transducers and activators of transcription. Proc Nat Acad Sci USA 91 4806-4810.
70. NG Copeland, DJ Gilbert, C Schindler, Z Zhong, Z Wen, et al. (1995) Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics 29(1), 225-228.
71. AL Wurster, T Tanaka and MJ Grusby (2000) The biology of Stat4 and Stat6. Oncogene 19(21), 2577-2584.
72. A Morinobu, M Gadina, W Strober, R Visconti, A Fornace, et al. (2002) STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci USA 99(19), 12,281-12,286.
73. Z Yao, Y Cui, WT Watford, JH Bream, K Yamaoka, et al. (2006) Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci USA 103(4), 1000-1005.
74. D Hebenstreit, G Wirnsberger, J Horejs-Hoeck and A Duschl (2006) Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 17(3), 173-188.